StockData
Claritev Corp logo

Claritev Corp (CTEV) stock

CTEVNYSEServices-Business Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$26.90−1.31 (-4.64%)

Close on Nov 12, 2026Market cap $455.89MP/E –Yield –

Earnings

Claritev's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 6, 2026
Q3 FY2026 · estimated, before the open
Revenue, Q2 FY2026
$257.50M
+6.6% on a year earlier
EPS, Q2 FY2026
–
-$3.81 a year earlier
Latest guidance
Raised
Aug 7, 2026 · 5 items

Quarterly results

Revenue and earnings per share from each of Claritev's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 6, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Aug 7, 2026before the open$257.50M+6.6%–Release
Q1 FY2026ended Mar 31, 2026May 7, 2026before the open$244.70M+5.8%–Release
Q4 FY2025ended Dec 31, 2025Feb 23, 2026after the close$246.60M+6.2%-$4.88Release
Q3 FY2025ended Sep 30, 2025Nov 7, 2025before the open$246.00M+6.7%-$4.23Release
Q2 FY2025ended Jun 30, 2025Aug 6, 2025before the open$241.60M+3.5%-$3.81Release
Q1 FY2025ended Mar 31, 2025May 8, 2025before the open$231.30M-1.4%-$4.38Release
Q4 FY2024ended Dec 31, 2024Feb 25, 2025before the open$232.10M-4.9%–Release
Q3 FY2024ended Sep 30, 2024Nov 5, 2024before the open$230.50M-5.1%–Release
Q2 FY2024ended Jun 30, 2024Aug 1, 2024before the open$233.50M-1.9%-$0.89Release
Q1 FY2024ended Mar 31, 2024May 8, 2024before the open$234.50M-0.9%-$0.83Release
Q4 FY2023ended Dec 31, 2023Feb 29, 2024before the open$244.10M+1.2%–Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Claritev's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
RevenuesFY2026$1.00B – $1.02B$985.00M – $1.00MRaisedAug 7, 2026
Adjusted EBITDAnon-GAAPFY2026$610.00M – $620.00M$605.00M – $615.00MRaisedAug 7, 2026
Free Cash Flownon-GAAPFY2026$5.00M – $15.00M$0 – $10.00MRaisedAug 7, 2026
Capital expendituresFY2026$160.00M – $170.00M$160.00M – $170.00MReaffirmedAug 7, 2026
Effective tax rateFY202624% – 28%24% – 28%ReaffirmedAug 7, 2026

Guidance vs results

The last range Claritev gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue growth+2.8% – +3.2%+3.75%Σ4QAbove range
Q3 FY2024Revenue$230.00M – $245.00M$230.50MWithin range
Q2 FY2024Revenue$235.00M – $250.00M$233.50MBelow range
Q1 FY2024Revenue$235.00M – $250.00M$234.50MBelow range
Q4 FY2023Revenue$240.00M – $250.00M$244.10MWithin range
Q3 FY2023Revenue$235.00M – $250.00M$242.80MWithin range
Q2 FY2023Revenue$220.00M – $235.00M$238.00MAbove range
Q1 FY2023Revenue$225.00M – $240.00M$236.60MWithin range
Q4 FY2022Revenue$235.00M – $250.00M$241.10MWithin range
Q3 FY2022Revenue$280.00M – $290.00M$250.50MBelow range
Q2 FY2022Revenue$285.00M – $295.00M$290.10MWithin range
Q1 FY2022Revenue$280.00M – $295.00M$298.00MAbove range

Guidance history

Every forecast Claritev put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Aug 7, 2026Capital expendituresFY2026$160.00M – $170.00MReaffirmed
Aug 7, 2026Adjusted EBITDAFY2026$610.00M – $620.00MRaised
Aug 7, 2026Free Cash FlowFY2026$5.00M – $15.00MRaised
Aug 7, 2026Effective tax rateFY202624% – 28%Reaffirmed
Aug 7, 2026RevenuesFY2026$1.00B – $1.02BRaised
May 7, 2026Capital expendituresFY2026$160.00M – $170.00MReaffirmed
May 7, 2026Adjusted EBITDAFY2026$605.00M – $615.00MReaffirmed
May 7, 2026Free Cash FlowFY2026$0 – $10.00MReaffirmed
May 7, 2026Effective tax rateFY202624% – 28%Reaffirmed
May 7, 2026RevenuesFY2026$985.00M – $1.00MNew
Feb 23, 2026Capital expendituresFY2026$160.00M – $170.00MNew
Feb 23, 2026Adjusted EBITDAFY2026$605.00M – $615.00MNew
Feb 23, 2026Free cash flowFY2026$0 – $10.00MNew
Feb 23, 2026Effective tax rateFY202624% – 28%New
Nov 7, 2025Capital expendituresFY2025$165.00M – $175.00MNew
Nov 7, 2025Free Cash FlowFY2025-$20.00M – $20.00MNew
Nov 7, 2025Adjusted EBITDA MarginFY202562.5% – 63%New
Nov 7, 2025Effective tax rateFY202525% – 28%New
Nov 7, 2025RevenuesFY2025+2.8% – +3.2%New
Aug 6, 2025Capital expendituresFY2025$170.00M – $180.00MRaised

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Claritev filed with the SEC as exhibits to Form 8-K or 6-K

  1. Claritev Appoints Jennifer Main to its Board of Directors
    Update
  2. Claritev Appoints Ben Letham to its Board of Directors
    Update
  3. Claritev Corporation Reports Second Quarter 2026 Results
    Results
  4. Claritev Corporation Reports First Quarter 2026 Results
    Results
  5. Confidential and Proprietary – Do not distribute without permission 1 New York Stock Exchange March 16, 2026 2026 Investor Day
    Update
  6. Claritev Corporation Reports Fourth Quarter and Full Year 2025 Results
    Results
  7. 4 01 Claritev Vision 02 Products and Offerings Agenda 03 Financial Overview
    Update
  8. Claritev Corporation Reports Third Quarter 2025 Results
    Results
  9. 3 01 Claritev Vision 02 Product and Offerings 03 Technology 04 Financial Overview Agenda 05 Strategic Growth Initiatives
    Update
  10. Claritev Corporation Reports Second Quarter 2025 Results
    Results
  11. Claritev Corporation Reports First Quarter 2025 Results
    Results
  12. 8-K exhibit EX-99.1
    Update
  13. Claritev Reports Fourth Quarter and Full Year 2024 Results with Initial Guidance for Full Year 2025
    Results
  14. MultiPlan Enters New Era and Unveils New Brand, Claritev, Reflecting Company’s Transformation and Mission to Support the Healthcare Continuum
    Update
  15. MultiPlan Announces Expiration and Results of
    News

See a number that looks wrong?